Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer

Recent breakthroughs in immune checkpoint inhibitors (ICIs) have shown promise in triple-negative breast cancer (TNBC). Due to the intrinsic heterogeneity among TNBC, clinical response to ICIs varies greatly among individuals. Thus, discovering rational biomarkers to select susceptible patients for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinguo, Pan, Shuaikang, Han, Chaoqiang, Jin, Hongwei, Sun, Qingqing, Du, Jun, Han, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687467/
https://www.ncbi.nlm.nih.gov/pubmed/36358906
http://dx.doi.org/10.3390/biom12111556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687467/
https://www.ncbi.nlm.nih.gov/pubmed/36358906
http://dx.doi.org/10.3390/biom12111556

Ejemplares similares